Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening

Area of Science:

• Genetics
• Neonatal Medicine
• Public Health

Background:

• Newborn screening is vital for early detection of genetic disorders.
• Current biochemical screening methods have limitations in detecting all monogenic disorders.
• The impact of genetic sequencing in general newborn populations requires evaluation.

Purpose of the Study:

• To assess the effectiveness of gene panel sequencing as a primary screening tool for newborns.
• To compare the diagnostic yield of gene panel sequencing against traditional biochemical screening.
• To determine the number of conditions uniquely identified by genetic sequencing.

Main Methods:

• A prospective cohort study involving 29,601 newborns across 8 screening centers in China.
• Concurrent screening using dried blood spots with biochemical tests and a 128-condition targeted gene panel.
• Follow-up of neonates with positive screening results.

Main Results:

• Gene panel sequencing identified 59 patients missed by biochemical tests.
• This included 39 cases of disorders screened solely by genetic methods.
• The study suggests that 1 in 500 newborns benefit from gene panel sequencing as a first-tier test.

Conclusions:

• Gene panel sequencing improves detection capabilities beyond traditional newborn screening.
• The findings support considering gene panel sequencing as a critical first-tier screening method.
• This genetic approach offers enhanced early detection of a wider range of newborn disorders.